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We sought to characterize sex-based differences in ac-
cess to deceased donor liver transplantation. Scientific
Registry of Transplant Recipients data were used to an-
alyze n = 78 998 adult candidates listed before (8/1997–
2/2002) or after (2/2002–2/2007) implementation of
Model for End-Stage Liver Disease (MELD)-based liver
allocation. The primary outcome was deceased donor
liver transplantation. Cox regression was used to esti-
mate covariate-adjusted differences in transplant rates
by sex. Females represented 38% of listed patients in
the pre-MELD era and 35% in the MELD era. Females
had significantly lower covariate-adjusted transplant
rates in the pre-MELD era (by 9%; p < 0.0001) and in
the MELD era (by 14%; p < 0.0001). In the MELD era,
the disparity in transplant rate for females increased
as waiting list mortality risk increased, particularly for
MELD scores ≥15. Substantial geographic variation in
sex-based differences in transplant rates was observed.
Some areas of the United States had more than a 30%
lower covariate-adjusted transplant rate for females
compared to males in the MELD era. In conclusion,
the disparity in liver transplant rates between females
and males has increased in the MELD era. It is espe-
cially troubling that the disparity is magnified among
patients with high MELD scores and in certain regions
of the United States.
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Introduction
Each year, thousands of patients with end-stage liver dis-
ease die awaiting liver transplantation. Since the organ
supply is overwhelmed by more than 17 000 candidates
waiting for a transplant, complex organ allocation rules
have developed, predicated on ensuring a fair distribution
of these resources to a heterogenous patient population.
Since 2002, deceased donor livers have been allocated to
candidates with chronic liver disease at the highest risk
of death, determined by the Model for End-Stage Liver
Disease (MELD) scoring system (1). MELD is based on
three laboratory tests—international normalized ratio (INR)
of the prothrombin time, total serum bilirubin and serum
creatinine—and is a reliable clinical tool for consistent, ac-
curate and objective estimation of short-term mortality in
a wide range of chronic liver disease patients, including
those awaiting liver transplantation (1–6). However, MELD
scores may underestimate mortality risk in women, as their
smaller stature and lesser muscle mass skews estimation
of their level of renal dysfunction, which is based solely
on serum creatinine (7–9). As a result, female priority for
liver transplantation may be devalued under MELD-based
allocation.
Previous authors have reported compromised access
among females in more general examinations of liver trans-
plant waiting list outcomes (10,11), and studies also show
that sex-based disparities exist in access to kidney trans-
plantation (12). However, a comprehensive analysis focus-
ing on the association between sex and liver transplant
rates has not been published. Improved understanding of
inequities in the liver transplant process requires a thor-
ough understanding of liver allocation and distribution,
which may create unintentional disparities when the fo-
cus is optimizing organ placement. In liver transplantation,
access to transplant is not solely dependent on candidate
medical urgency as assessed by MELD score. Organs are
offered first to candidates listed at transplant programs
within a geographic distribution unit that represents the
donation service area (DSA) of the donor hospital. Differ-
ential organ acceptance practices and geographic differ-
ences in organ availability generate substantial variation in
transplant rates within each of the 50 DSAs in the United
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States where liver transplants are performed (13,14). Anal-
yses of liver allocation and disparities in its process should
therefore account for the DSA as well as MELD.
In this study, we characterized the effect of sex on rates
of liver transplantation among listed candidates. We hy-
pothesized that female liver transplant candidates are less
likely to receive liver grafts, even after controlling for con-
founders such as patient differences, medical urgency and
disease progression, and geography. We also sought to
examine the complex relationships among geography, di-
agnosis and sex to investigate potential mechanisms un-
derlying sex-based disparities in successful matriculation
from the liver transplant waiting list.
Methods
We used data from the Scientific Registry of Transplant Recipients (SRTR)
based on patient-level data submitted by all U.S. transplant centers to
the Organ Procurement and Transplantation Network (OPTN). The ob-
servational study cohort was comprised of n = 78 998 adult candi-
dates with end-stage liver disease. The cohort and follow-up was divided
into pre-MELD and MELD eras based on the date of candidate regis-
tration. Pre-MELD patients were those initially registered on the wait-
ing list between February 28, 1997 and February 27, 2002. The OPTN
adopted a MELD-based liver allocation policy in February 2002, and pa-
tients were classified as MELD era if they were initially added to the
waiting list between February 28, 2002 and February 27, 2007. Status
1, pediatric patients and patients with hepatocellular carcinoma were ex-
cluded, as were patients with MELD exception scores at initial waiting list
registration.
The primary exposure variable was sex. Candidate follow-up time at risk
began on the date of initial waiting list registration and continued until the
earliest of deceased donor liver transplant (the event of interest), death,
granting of a MELD exception score not based on laboratory values, non-
death removal from the waiting list, receipt of a living donor liver transplant
or the end of the observation period. Aside from deceased donor liver trans-
plant, all other waiting list outcomes (e.g. death, nondeath removal, granting
of an exception score) were treated as nonevents. Follow-up time at risk
was suspended during any periods when candidates were designated as
temporarily inactive, and observation was subsequently reinitiated upon re-
activation, if applicable. Borrowing terminology from competing risks statis-
tics (15), our analysis compared, by sex, cause-specific deceased-donor liver
transplant rates; i.e. rates of transplant among patients actually eligible for
transplant: alive, not removed and active on the wait list.
Cox regression models were fitted to estimate the effect of sex on rates
of deceased donor liver transplantation with adjustment for confounding
covariates. We accounted for geographic variation and medical urgency
using models stratified for these factors (16). We fitted separate models
for the pre-MELD and MELD eras, and fitted a combined model with fe-
male × era interaction terms. Each model was stratified by geography
(DSA) and medical urgency (vide infra). Stratified Cox proportional hazards
models assume varying hazard functions for receipt of a liver transplant
within each stratum, which in the geographic context was represented by
each of the 50 DSAs that participate in liver transplantation in the United
States. We assumed that patients in different DSAs had intrinsically differ-
ent likelihoods of receiving a liver transplant based on the variation in organ
donation, differences in waitlisting practices and provider differences within
DSAs.
Since sicker patients receive greater allocation priority, we also stratified the
models on medical urgency. This prioritization was delineated by medical
urgency status (status 2A, 2B or 3) in the pre-MELD era or MELD score in
the MELD era. In the pre-MELD era, medical urgency status was defined
by Child–Turcotte–Pugh (CTP) score and hospitalization category (1). Three
status definitions were used for candidates in this era: status 2A, for pa-
tients registered while being treated in the intensive care unit with a CTP
score greater than 10; status 2B, for patients hospitalized at the time of
registration with CTP scores greater than 10; and status 3, for outpatients
with CTP scores from 7 to 9. In the MELD era, patients were grouped by
integer MELD score: 6, 7, . . . , 39, 40.
The analysis was adjusted for covariates recorded in the SRTR liver trans-
plant candidate file, including age, height, weight, race/ethnicity, diagnosis,
blood type, diabetes, body mass index (BMI), hospitalization status at list-
ing, receipt of dialysis (MELD era), albumin (MELD era) and prior malignancy.
Status (in the pre-MELD era), MELD (in the MELD era), serum albumin and
requirement for dialysis were treated as time-dependent covariates, since
they could be updated multiple times during patient follow-up. Less than
10% of all data were missing. Candidates with missing data elements
were excluded from the analysis, and this was similar for both sexes. Re-
sults are expressed as differences in relative transplant rates, based on
hazard ratios (HRs) estimated relative to a reference group assigned a HR
of 1.00.
All statistical analyses were performed using SAS v9.2 (SAS Institute; Cary,
NC). Statistical significance was defined by p < 0.05. This study was ap-
proved by the U.S. Health Resources and Services Administration (HRSA)
SRTR project officer. HRSA has determined that this study satisfies the
criteria for the IRB exemption described in the ‘Public Benefit and Service
Program’ provisions of 45 CFR 46.101(b) (5) and HRSA circular 03.
Results
Baseline demographics and disease severity
Of the n = 78 998 candidates included in the analysis,
36.4% were female (n = 28 759) and 63.6% were male
(n = 50 239). There were similar proportions of female
candidates in the pre-MELD and MELD eras (37.8% and
35.0%, respectively). Table 1 displays the clinical character-
istics of male and female candidates in the study cohort.
Slightly more than half of all the females in the cohort
were listed in the pre-MELD era. The reverse was true
for males. Overall, female and male candidates were of
similar age. African Americans and Hispanics had propor-
tionally greater representation among female candidates.
The proportion of females with cholestatic liver disease
was twofold higher than males, and fewer females had
hepatitis C-related cirrhosis. Male and females had similar
BMI and dialysis requirements at listing.
There were significant differences in disease severity at
the time of listing between males and females. In the pre-
MELD era, similar proportions of female and male candi-
dates were initially listed as status 2A (3.5% vs. 3.9%,
respectively), but 21.6% of females were listed as status
2B compared to 27.0% of males. Females had proportion-
ally more status 3 designations at the time of waitlisting,
which represented the minimum listing criteria in the pre-
MELD era (75.0% vs. 69.1%, respectively). In the MELD
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Table 1: Clinical characteristics of male and female liver transplant waitlist candidates in the study cohort
Males Females
Variable (n = 50 239) (n = 28 759) p-Value
Age at waitlist registration (years) (SD) 51.23 (9.16) 51.94 (10.56) <0.0001
Race <0.0001
White (%) 38 465 (76.56) 20 706 (72.00)
African American (%) 3 155 (6.28) 2 490 (8.66)
Hispanic (%) 6 226 (12.39) 4 221 (14.68)
Asian (%) 1 998 (3.98) 1 047 (3.64)
Other (%) 395 (0.79) 295 (1.03)
Era <0.0001
Pre-MELD era (n) 24 749 (49.26) 15 056 (52.35)
MELD era (n) 25 490 (50.74) 13 703 (47.65)
Diagnosis <0.0001
Cholestatic (n) (%) 3 360 (6.69) 4 395 (15.28)
Noncholestatic (n) (%) 17 524 (34.88) 10 260 (35.68)
Acute hepatic necrosis (n) (%) 897 (1.79) 773 (2.69)
Malignant neoplasm (non-HCC) (n) (%) 1 205 (2.40) 428 (1.49)
Metabolic disease (n) (%) 1 022 (2.03) 447 (1.55)
Hepatitis C (n) (%) 22 912 (45.61) 9 771 (33.98)
Other (n) (%) 3 319 (6.61) 2 685 (9.34)
MELD score at listing, (mean) (SD) 14.55 (7.86) 13.57 (7.76) <0.0001
MELD score at listing, (median) (25th, 75th percentile) 13 (8, 18) 12 (7, 17)
MELD score at transplant (median) (25th, 75th percentile) 18 (13, 25) 18 (13, 25)
Pre-MELD era status <0.0001
Status 2A 964 (3.90) 521 (3.46)
Status 2B 6 678 (26.98) 3 245 (21.55)
Status 3 17 107 (69.12) 11 290 (74.99)
Hospitalization in Intensive care unit at registration (n) (%) 1 872 (3.7) 1 174 (4.1) 0.01
Mechanical ventilation support at registration (n) (%) 644 (1.3) 443 (1.5) 0.003
Diabetes mellitus (n) (%) 6 717 (13.4) 4 076 (14.2) 0.002
Mean body mass index 28.38 (6.21) 28.29 (7.07) 0.07
Renal failure (% dialysis) 1 290 (2.57) 609 (2.12) <0.0001
Angina (n) (%) 1 224 (2.4) 456 (1.6) <0.0001
Chronic obstructive pulmonary disease (n) (%) 756 (1.5) 413 (1.4) 0.44
Cerebral vascular disease (n) (%) 310 (0.6) 181 (0.6) 0.83
Peripheral vascular disease (n) (%) 507 (1.0) 140 (0.5) <0.0001
era, females were listed with a lower median MELD score
compared to males (12 vs. 13, p < 0.0001). Above MELD
15, proportionally fewer females were listed at each in-
dividual MELD score. In both the pre-MELD and MELD
eras, females tended to be placed on the waiting list with
less severe liver disease. Clinically, rates of ICU hospitaliza-
tion and mechanical ventilation at registration were similar
between the sexes, but due to large sample size, were
significantly different statistically. Males and females had
statistically significant differences in medical comorbidi-
ties including BMI, dialysis dependence, angina, chronic
obstructive pulmonary disease and diabetes mellitus, but
these respective differences were not clinically significant.
Males had higher rates of peripheral vascular disease at
registration versus females.
Access to liver transplantation in the pre-MELD and
MELD eras
As illustrated in Figure 1, after adjusting for clinical fac-
tors, medical urgency status designation and DSA in the
pre-MELD era, females had a significant 9% (p < 0.0001)
lower transplant rate compared to males, with a covariate-
adjusted HR of 0.91 and 95% confidence interval (CI)
(0.87, 0.94). This pre-MELD era disparity increased to 14%
(p < 0.0001) for females in the MELD era, adjusted for the
same clinical factors, MELD score and DSA; HR = 0.86
(0.83, 0.89). The increase in the disparity from the pre-
MELD era to the MELD era was significant (p = 0.004).
Sex-race interactions were not significant. Interactions be-
tween primary diagnosis and sex were also tested, and
were nonsignificant.
The pre-MELD era disparity was largest among status
2B candidates, where females had a 12% lower trans-
plant rate (p < 0.05) compared to their male counterparts;
HR = 0.88 (0.84, 0.92) (Figure 2). Transplant rates were
also lower among females listed as status 2A and status 3,
but these differences were not statistically significant. In
the MELD era, females with MELD scores less than 15 did
not have significantly different transplant rates than males
with similar medical urgency, but the disparity was marked
and significant among females with MELD scores ≥15
(Figure 3). Transplant rates were 20% lower for females
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Figure 1: Sex-based disparities in
liver transplant rates in the pre-
MELD and MELD eras. After adjust-
ing for several patient-level factors and
stratifying by the DSA and status or
MELD score of the patient, females
had lower relative transplant rates in
both eras compared to men, with a 9%
deficit in the pre-MELD era and a 14%
deficit in the MELD era. This widening
of the gap in liver transplant rates be-
tween males and females was signifi-
cantly worse in the MELD era, based
on female × era interaction models
(p = 0.004).
Figure 2: Lower relative transplant
rates for status 2B females in the
pre-MELD era. Among the three sta-
tus designations included in the study
(status 2A, 2B and 3), females only had
significantly lower relative transplant
rates than men when registered as sta-
tus 2B. By definition, status 2B candi-
dates were hospitalized at the time of
registration with Child–Turcotte–Pugh
scores of 7–10.
Figure 3: Females with higher MELD
scores have less access to liver trans-
plant than males. In the MELD era,
the disparity in transplant rates be-
tween men and women was visible
only in those candidates with MELD
scores greater than 15. As the MELD
scores increased, the deficit between
men and women widened. These
lower transplant rates were not accom-
panied by any changes in the adjusted
relative rates of any other waiting list
events, including death, removal or in-
activation.
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Figure 4: The effect of candidate
sex on liver transplant waiting list
events in the MELD era. Several
events may occur after registration on
a liver transplant waiting list, including
receipt of a liver transplant, death while
waiting on the list, being removed from
the list due to an illness precluding
transplantation or temporary inactiva-
tion for a period of time. We have
modeled the effect of sex on each of
these transitions, which is captured by
the hazard ratios above each arrow. As
in Figure 1, males have significantly
higher transplant rates than females,
and also have a significantly higher rel-
ative rate of removal from the waiting
list. There are no statistically signifi-
cant sex-based differences in waiting
list mortality or inactivation, after ad-
justing for MELD score and geography.
with MELD scores 20–29 (p < 0.05), with HR = 0.80 (0.70,
0.90). Even among candidates with the highest MELD
scores (MELD 30–40), females had a 12% lower (p < 0.05)
transplant rate, with HR = 0.88 (0.84, 0.92).
We further evaluated the association between candidate
sex and other waiting list events in both eras, including
death on the waiting list, inactivation and nontransplant re-
moval from the waiting list. Prior to the MELD era, females
had a 13% lower adjusted waiting list mortality rate com-
pared to males (HR = 0.87, p = 0.0004), but this disparity
was not seen in the MELD era (HR = 1.08, p = 0.196). In-
activation rates were similar between males and females
in both eras. Female sex was associated with a 9% lower
nontransplant removal rate versus males in the pre-MELD
era (HR = 0.91, p < 0.0001). We observed this in the MELD
era as well (HR = 0.89, p < 0.0001). Figure 4 summarizes
these effects for MELD era candidates.
Additionally, we evaluated potential interactions between
body size and female sex. In particular, we fitted mod-
els which allowed the female/male contrast in transplant
rates to depend on height quartile, and results were highly
nonsignificant. It thus appears that the reduction in liver
transplant rates among females, relative to males, does
not depend on candidate height (data not shown).
Geographic variation in sex-based disparities in liver
transplant rates
We evaluated which geographic areas of the United States
had the largest sex-based disparities in transplant rates in
both the pre-MELD and MELD eras by evaluating disease
severity and DSA-adjusted transplant rates within the 11
OPTN regions used in organ allocation (Figure 5). In the
pre-MELD era, three regions displayed a more than 10%
sex-based disparity in liver transplant rates—regions 1, 2
and 10, representing New England, parts of the middle
Atlantic, and the states of Indiana, Michigan and Ohio, re-
spectively. These areas displayed 16–22% lower transplant
rates for females compared to males with similar disease
burden in the same region. There were no significant dif-
ferences between females and males in the other eight
OPTN regions in the pre-MELD era.
In the MELD era, the geographic distribution of sex-
based disparities in relative transplant rates was more pro-
nounced. Females had significantly lower transplant rates
in 6 of the 11 OPTN regions, with a maximum deficit
of 35% in the Pacific Northwest (region 6). The geo-
graphic areas demonstrating these disparities included the
southeastern and southwestern United States, Texas, Ok-
lahoma, California, the Pacific Northwest, Alaska, Hawaii,
parts of the Midwest, the Carolinas, Virginia, Tennessee
and Kentucky. Only region 10 had a significant sex-based
transplant rate disparity in both eras. Sex-based disparities
in access to liver transplantation in the MELD era were
therefore both geographically extensive and of variable
magnitude.
Discussion
The results of this study demonstrate that female can-
didates have markedly lower liver transplant rates than
their male counterparts. This disparity is geographically
widespread and has worsened under recent changes in
deceased donor liver allocation policy in the United States.
Furthermore, the deficit in the transplant rate among fe-
males was concentrated among those candidates at the
highest risk of death on the waiting list, including those
whose transplants are associated with the most survival
benefit (17). Under the current allocation system, both
sexes had similar respective risk-adjusted waiting list mor-
tality rates and inactivation, but females were less likely
to be removed from the waiting list. This suggests that
females are remaining on the waiting list, while males are
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Figure 5: Geographic variation in female access to liver transplantation. In the pre-MELD era, the majority of the United States
did not display any deficits in the relative liver transplant rates between men and women. In three Organ Procurement and Transplant
Network (OPTN) regions, there was at least a 10% lower transplant rate for women. Region 1 displayed a greater than 20% lower
liver transplant rate for women compared to men during that period. In the MELD era, sex-based differences in adjusted relative liver
transplant rates were common across the United States. The majority of OPTN regions displayed lower transplant rates for women. Only
one region, region 10, displayed failures in sex equity in both eras.
more likely to receive a transplant or are removed for being
too sick.
Studies published to date on sex-based disparities in ac-
cess to liver transplantation have provided limited un-
derstanding of this important problem. Three studies
have demonstrated reduced access for female candidates
(10,11,18). We found a somewhat smaller magnitude dif-
ference in sex-specific transplant rates, but have shown
that the difference has significantly worsened, rather than
improved, under current allocation rules. This novel ob-
servation was likely revealed by our carefully considered
adjustment strategy for geography and MELD, and is op-
posite to the temporal trend described by Moylan et al.
(10). The previous studies underestimated how transplant
rates are affected by disease progression over time and
the local allocation environment.
Importantly, our findings of significantly lower transplant
rates among females with MELD scores above 15 are es-
pecially concerning. At MELD scores above 12–15, the
calculated life years from a liver transplant exceed the
projected lifetime without one (17,19). This survival
benefit increases as MELD increases. Our findings there-
fore suggest that female candidates lose a major survival
benefit as a result of the observed disparity in transplant
rates. Provider and practice alterations in response to cur-
rent allocation rules may be responsible for these obser-
vations, by unintentionally keeping females on the waiting
list, while maintaining lower transplant and removal rates
compared to males. Differences in MELD progression by
sex may also be present, but this has not been validated
and should be studied further. Secular changes in donor
characteristics may also play a role, as size constraints
are a clear part of transplant surgical decision making. In
summary, although there is not a precise explanation for
worsened sex inequity in the MELD era, this observation
remains ripe for further investigation.
The breadth and diversity of geographic elements of the
sex-based disparity in the MELD era is another important
finding. Geographic variation in overall access to transplan-
tation is well recognized in both kidney and liver trans-
plantation (20–22), but these studies were not designed to
examine the interactions between a candidate’s sex, race,
location and transplant access. We have demonstrated that
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in 28 U.S. states, females had more than a 10% lower
transplant rate than males with the same MELD scores.
Previous analyses by the SRTR also suggest that wait-list
events rates vary by geography (13), so it is not surprising
that a disparity in these event rates also differs based on
location. However, geographic differences in female liver
transplant rates could represent otherwise concealed un-
recognized sex-biased practice patterns and provider be-
haviors that may arise in the acceptance of donor livers,
and be integrated into local patterns of clinical care. Test-
ing of this hypothesis would require data beyond what is
currently available to the SRTR, but could be addressed
using survey methodology, mixed methods or other
approaches.
Female sex plays a role in the navigation of the transplant
process for other organs (23). In kidney transplantation,
females with end-stage renal disease had lower waitlist-
ing and transplant rates compared to males (12,24,25).
Disparate access to health care for women also extends
beyond transplantation. In cardiovascular disease and on-
cology, female patients were less likely to undergo rec-
ommended invasive cardiac procedures, and less likely
to receive optimal cancer treatments compared to males
(26–31).
Health disparities may arise from unequal treatment driven
by conscious or less explicit provider behaviors (29,32,33).
In the case of liver transplantation, receipt of a liver allograft
is dependent not only on the candidate being sick enough
to warrant a transplant. She must be at the top of the wait-
ing list, receive an offer of a suitable donor liver, and have
that offer accepted on her behalf by the transplant surgeon.
Numerous factors contribute to the decision to accept or
decline a liver offer. For example, the donor liver may be
declined if it is deemed too large for a small-sized candi-
date, or a higher risk graft may be declined for a particular
candidate. Transplant surgeons may deem female candi-
dates to be not as medically urgent as their MELD scores
suggest in the absence of major complications of cirrhosis
or portal hypertension. Even in the absence of overtly iden-
tifiable provider bias against female candidates, isolation of
the presumptively independent association of sex with or-
gan offer decisions will soon be possible. With the recent
adoption of DonorNet, a nationwide electronic organ offer
system used by all U.S. transplant centers (34), data on all
organ offers are being captured and may be used to directly
test this hypothesis.
Our analysis showed striking inequalities in transplant ac-
cess by sex, but the results are subject to some limitations.
We considered only adults with chronic liver disease in our
model and patients with hepatocellular carcinoma were ex-
cluded because of the existence of a separate preference
pathway for access to donor organs. Hepatocellular carci-
noma is a common indication for adult deceased donor liver
transplantation (35), and sex-based disparities in transplant
access may be present to a different degree in this patient
group. Our approach specifically accounted for allocation-
related factors, but was not designed to assess the role of
donor factors. Despite these limitations, our study is the
most comprehensive to date, and contributes to our knowl-
edge on the effect of sex on access to liver transplantation
from the waiting list.
From a methodological standpoint, our analysis was de-
signed to determine whether sex-based disparities exist in
the transition from liver transplant candidate to transplant
recipient. Several factors affect the rate of this transition,
and several outcomes are possible for liver transplant can-
didates: deactivation, removal, transplant and death. These
outcomes can be considered competing risks (15). Our
primary interest was in determining differences in trans-
plant rates between males and females. To this end, sev-
eral statistical approaches can be applied. One approach
would be to compare the sex-specific cumulative incidence
of liver transplantation (36), i.e. the probability that a pa-
tient undergoes transplantation. Comparisons of cumu-
lative incidence can be difficult to interpret since, in the
context of the liver transplant waiting list, differences in
the sex-specific cumulative incidence of liver transplan-
tation could result from differences in mortality, removal
for nondeath causes, deactivation, and/or actual dispari-
ties present in the process (37). To remove this poten-
tial source of bias, we analyzed cause-specific rates of
the liver transplant event, i.e. the rate of transplant, given
that no other competing risk has occurred (15). This ap-
proach provides an accurate estimate of the sex-based
differences in transplant rates among patients who are
alive, on the wait list, not removed and not deactivated,
or more plainly, the transplant rate differences among pa-
tients actually eligible for transplant. Unlike the cumulative
incidence approach, the cause-specific rates do not ‘inter-
act’ with each other. For example, compared to females,
knowing that males have higher rates of removal while
listed and alive need not imply that they have lower rates
of transplant while alive and not removed. From this per-
spective, comparisons of cause-specific transplant rates
were more relevant to our objectives and are easier to inter-
pret. Additionally, since our interest was in the mechanics
of the allocation system, and since organs are allocated
only to alive, nonremoved, active candidates, it makes
sense to compare sex-specific transplant rates using this
approach.
Surgical advances and new policy development may help
remediate the transplant rate deficit for female candidates.
For example, female liver transplant candidates may con-
sider the option of living donor liver transplantation (38–
41). The use of split liver grafts from deceased donors for
smaller adult female recipients is also gaining favor, but re-
quires further study (42). Finally, the transplant community
has the opportunity and responsibility to amend liver allo-
cation rules as circumstances warrant. Thus, several tools
are available to increase equity between the sexes in liver
transplantation.
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In summary, sex-based disparities in liver transplant rates
have increased over the last decade. Under current al-
location rules, there are geographically pervasive dispari-
ties in female access to deceased donor liver transplants,
and these disparities are concentrated among those candi-
dates most likely to benefit from liver transplantation. Our
analysis of other waiting list event rates suggests that fe-
males may be disproportionately surviving on the waiting
list. Future efforts should be directed toward understand-
ing the genesis of these inequities, with the goal of achiev-
ing more equitable access to liver transplantation for all
candidates.
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